Cancer Stem Cells Market, By Cancer Type (Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others), By Mode of Action (Targeted CSCs, Stem Cell based Cancer Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Cancer Stem Cells  Market was valued at US$ 1.4 Billion in 2024 and is projected to grow at a CAGR of 1.50% to reach US$ 4Billion by 2034.

Cancer Stem Cells are subpopulation of cells within tumors with capacity of differentiation, self-renewal and tumorigenicity when transplanted in host of animal. CD133, CD44 and CD24 are various cell surface markers used to identify and enrich Cancer Stem Cells.

Growing prevalence of cancer diseases has provided lucrative opportunities in target market growth. Advancement in stem cells and its successful utilization in immuno-reconstitution has further, boost the market growth. Cancer stem cells combat tumor progression by enabling therapeutic development and become as potential therapeutic targets.

 

Growing Prevalence of Cancer Diseases to Favor Market Growth

Growing prevalence of cancer diseases is one of the leading factors for the Cancer Stem Cells Market growth. Unhealthy and sedentary lifestyle, poor nutrition food, excess use of alcohol and trend of smoking has given rise in burden of cancer diseases. Stem cells replace bone marrow cells destroyed by cancer and plays an important role in cancer metastasis and relapse which in turn, facilitated the demand for Cancer Stem Cells market growth.

For instance, in 2019, according to CDC (Centers for Disease Control and Prevention), around 1,752,735 new cancer cases were reported and 599,589 people were died of cancer in United States.

Restrains:

However, potential risk regarding unproven stem cell treatment in cancer such as growth of tumors, injection site reaction, bacterial infections, ability of cells to change into inappropriate cell types, potential for contamination of product and failure of cells to work as expected and product recall has hampered the demand for Cancer Stem Cells market growth.

For instance, in December 2019, FDA (Food and Drug Administration), warned to companies Liveyon Labs inc., and Liveyon LLC., for offering unapproved umbilical cord blood products which represent potential risk in patient health. FDA has also send warning letter to Chara Biologics Inc., and RichSource Stem Cells Inc., for offering unapproved stem cell products which may put potential risk to public health.

Cancer Stem Cells Market is segmented based on Cancer Type, Mode of Action and region.

Cancer Type Insight

On the basis of Cancer Type, Cancer Stem Cells Market is segmented into Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others. Breast Cancer segment is expected to dominate the market growth due to growing incidence of breast cancer diseases.

For instance, according to ‘The World Cancer Report 2020’ it was determined that incidence of breast cancer is consistently rising in India due to high socio-economic status and rapid urbanization.

Mode of Action Insights

On the basis of Mode of Action, Cancer Stem Cells Market is segmented into Targeted CSCs, Stem Cell based Cancer Therapy. Targeted CSCs segment is expected to dominate the market growth due to growing research and development activities in cancer stem cells biology and its major signaling pathways by using recombinant proteins, monoclonal antibodies, natural compounds and nano-materials.

Regional Insights:

On region the Cancer Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period. Moreover, growing prevalence of cancer disease, continuous technological innovation, presence of major organizations in research and development activities regarding stem cell therapy, robust healthcare infrastructure, well-advanced cancer research and institutes is anticipated to increase demand for Cancer Stem Cells in the region.

Asia Pacific market is expected to be promising region due to funding agencies to accelerate scientific research on cancer stem cells and presence of major organizations that focus on research and development activities in cancer stem cells.

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Cancer Type - Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others By Mode of Action - Targeted CSCs, Stem Cell based Cancer Therapy
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Cancer Stem Cells Market report based on Cancer Type, Mode of Action and region:

Cancer Stem Cells Market, By Cancer Type:

• Blood Cancer
• Breast Cancer
• Bladder Cancer
• Lung Cancer
• Liver Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Cancer Stem Cells Market, By Mode of Action:

• Targeted CSCs (Cancerous Stem Cells)

• By Anti-CSC Therapeutics
• Pathway Inhibitors

• Notch Signaling Pathway
• Hedgehog Signaling Pathway
• WNT Signaling Pathway
• Others

• Surface Marker-based
• Nanoparticle-based Therapies
• Immuno-evasion & Targeting Tumor Microenvironment
• Others

• Products

• Cell Analysis
• Cell Separation
• Cell Culturing
• Molecular Analysis
• Others

• Stem Cell-based Cancer Therapy

• Allogeneic SC Transplant
• Autologous SC Transplant

Cancer Stem Cells Market, By Region:

 

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Cancer Stem Cells Market includes, AbbVie Inc., Thermo Fisher Scientific Inc., Merck KGaA, Stemline Therapeutics Inc., OncoMed Pharmaceuticals Inc., PromoCell GmbH, Miltenyi Biotec, Irvine Scientific, Sino Biological Inc., STEMCELL Technologies Inc., and others.

Recent Development:

• In April 2023, SynCo Bio Partners B.V., signed an agreement with OncoMed Pharmaceuticals a company who develops novel therapeutics which target cancer stem cells. This agreement will allow SynCo to fill and finish batches of OncoMed’s lead product “OMP-21M18’ antibody for Phase I clinical trials.
• In October 2022, FUJIFILM Irvine Scientific Inc., announced its PRIME-XV Stem FreezlS DMSO-Free cryopreservation medium is to be used as an excipient in FDA (Food and Drug Administration) authorized clinical trial conducted by Vitropharma to investigate safety and efficacy of intravenous infusion of stem cell therapy product.

• AbbVie Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Stemline Therapeutics Inc.
• OncoMed Pharmaceuticals Inc.
• PromoCell GmbH
• Miltenyi Biotec
• Irvine Scientific
• Sino Biological Inc.
• STEMCELL Technologies Inc.

“*” marked represents similar segmentation in other categories in the respective section

 

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Cancer Type
     • Market Snippet, By Mode of Action
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Cancer Stem Cells Market, By Cancer Type
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
     • Y-o-Y Growth Analysis (%), 2022 – 2032
     • Segment Trends
   • Blood Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Breast Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Bladder Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Lung Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Liver Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
6. Cancer Stem Cells Market, By Mode of Action, 2022 – 2032, (US$ Bn)
   • Overview                                      
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
     • Y-o-Y Growth Analysis (%), 2022 – 2032
     • Segment Trends
   • Targeted CSCs
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
   • Stem Cell based Cancer Therapy
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
7. Cancer Stem Cells Market, By Region, 2022 – 2032, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
     • Y-o-Y Growth Analysis (%), 2022 – 2032
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Cancer Type, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Mode of Action, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Cancer Type, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Mode of Action, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Cancer Type, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Mode of Action, 2022 – 2032
     • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific

• • Latin America
    • Market Size and Forecast (US$ Bn), By Cancer Type, 2022 – 2032
    • Market Size and Forecast (US$ Bn), By Mode of Action, 2022 – 2032
    • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
• • • • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Cancer Type, 2022 – 2032
    • Market Size and Forecast (US$ Bn), By Mode of Action, 2022 – 2032
    • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032

 

1. • • • GCC
       • Israel
       • South Africa
       • Rest of Middle East
2. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
3. Company Profiles 

• AbbVie Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Merck KGaA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Stemline Therapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• OncoMed Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• PromoCell GmbH
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Miltenyi Biotec
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Irvine Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sino Biological Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• STEMCELL Technologies Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. The Last Word
   • Future Impact
   • About Us
   • Contact